Year: 2026
Type: article
Abstract: This review focusses on the use of pharmacological therapies in the management of Inflammatory bowel disease (IBD). Understanding the pathophysiology of IBD has guided the development of medical therapies. This review discusses the shift towards a more personalised approach to IBD management and aims to improve the surgeons' understanding of available pharmacological agents. We discuss the use of immunomodulators and biologics, plus potential adverse reactions and contraindications. Lastly, we discuss future pharmacological therapies.
Source: ANZ Journal of Surgery
DOI: 10.1111/ans.70969
Institution: Princess Alexandra Hospital
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7212385590